Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
复制标题
双靶向明胶酶纳米粒子联合递送盐霉素和多西紫杉醇可有效抑制宫颈癌细胞和癌症干细胞
DOI:
10.1080/10717544.2021.1886378
复制
发表时间:
2021-12
期刊:
影响因子:
6
通讯作者:
Liu B
中科院分区:
文献类型:
--
作者:
Wang Q;Yen YT;Xie C;Liu F;Liu Q;Wei J;Yu L;Wang L;Meng F;Li R;Liu B
Abstract Intra-tumor heterogeneity is widely accepted as one of the key factors, which hinders cancer patients from achieving full recovery. Especially, cancer stem cells (CSCs) may exhibit self-renewal capacity, which makes it harder for complete elimination of tumor. Therefore, simultaneously inhibiting CSCs and non-CSCs in tumors becomes a promising strategy to obtain sustainable anticancer efficacy. Salinomycin (Sal) was reported to be critical to inhibit CSCs. However, the poor bioavailability and catastrophic side effects brought about limitations to clinical practice. To solve this problem, we previously constructed gelatinase-stimuli nanoparticles composed of nontoxic, biocompatible polyethylene glycol-polycaprolactone (PEG-PCL) copolymer with a gelatinase-cleavable peptide Pro-Val-Gly-Leu-Iso-Gly (PVGLIG) inserted between the two blocks of the copolymer. By applying our “smart” gelatinase-responsive nanoparticles for Sal delivery, we have demonstrated specific accumulation in tumor, anti-CSCs ability and reduced toxicity of Sal-NPs in our previous study. In the present study, we synthesized Sal-Docetaxel-loaded gelatinase-stimuli nanoparticles (Sal-Doc NP) and confirmed single emulsion as the optimal method of producing Sal-Doc NPs (Sal-Doc SE-NP) in comparison with nanoprecipitation. Sal-Doc SE-NPs inhibited both CSCs and non-CSCs in mice transplanted with cervical cancer, and might be associated with enhanced restriction of epithelial-mesenchymal transition (EMT) pathway. Besides, the tumorigenic capacity and growing speed were obviously suppressed in Sal-Doc-SE-NPs-treated group in rechallenge experiment. Our results suggest that Sal-Doc-loaded gelatinase-stimuli nanoparticles could be a promising strategy to enhance antitumor efficacy and reduce side effects by simultaneously suppressing CSCs and non-CSCs.
登录
查看更多内容
影响因子:
8
作者:
Liu Q;Li RT;Qian HQ;Yang M;Zhu ZS;Wu W;Qian XP;Yu LX;Jiang XQ;Liu BR
通讯作者:
Liu BR
DOI:
10.1073/pnas.1513433112
发表时间:
2015-08-18
影响因子:
11.1
作者:
Lu, Haiquan;Samanta, Debangshu;Semenza, Gregg L.
通讯作者:
Semenza, Gregg L.
影响因子:
9.7
作者:
Cui, Fang-bo;Li, Ru-Tian;Liu, Bao-Rui
通讯作者:
Liu, Bao-Rui
影响因子:
2.3
作者:
Li, Lan;Cui, Dejun;Cao, Yu
通讯作者:
Cao, Yu
影响因子:
5.8
作者:
Muntimadugu, Eameema;Kumar, Rajendra;Khan, Wahid
通讯作者:
Khan, Wahid